소 백신 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Cattle Vaccine was estimated to be worth US$ 1680 million in 2024 and is forecast to a readjusted size of US$ 2576 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.

A cattle vaccine is a biological preparation designed to help cattle (both beef and dairy) develop immunity against specific infectious diseases.

It contains weakened, killed, or inactivated pathogens (or parts of them, such as proteins or toxins) that stimulate the cow's immune system to recognize and fight the disease without causing the disease itself. In 2024, global cattle vaccines production reached approximately 160 million units , with an average global market price of around US$ 10.5 per unit.

Global outbreaks of infectious bovine diseases-such as Foot-and-Mouth Disease (FMD), Bovine Respiratory Disease Complex (BRDC), Brucellosis, and Bovine Viral Diarrhea (BVD)-are increasing vaccination adoption rates. These diseases can cause massive productivity and economic losses in the livestock industry, making preventive vaccination an essential part of herd management.

Increasing demand for high-quality beef and dairy products, especially in Asia-Pacific and Latin America, is pushing farmers to invest in vaccines to maintain herd productivity and product safety.

Many regions (e.g., EU, parts of South America, India) implement government-subsidized or mandatory cattle vaccination programs to control endemic diseases, ensuring market stability.

Development of recombinant DNA vaccines, subunit vaccines, and mRNA-based veterinary vaccines is accelerating, improving efficacy and reducing adverse reactions.

Multi-disease vaccines are gaining popularity for reducing labor costs and stress on animals during administration.

Especially important for developing countries, thermostable vaccines reduce dependency on cold chain logistics.

This report aims to provide a comprehensive presentation of the global market for Cattle Vaccine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cattle Vaccine by region & country, by Type, and by Sales Channel.

The Cattle Vaccine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cattle Vaccine.

Market Segmentation

By Company

• Merck Animal Health
• Zoetis
• Boehringer Ingelheim
• Ceva
• Zoetis
• Elanco Animal Health
• Indian Immunologicals
• Cambridge Technologies
• Vaxxinova
• Jinyu Bio-Technolog
• China Animal Husbandry Industry
• Tecon Biology

Segment by Type

• Live Attenuated Vaccine
• Inactivated Vaccine
• Others

Segment by Sales Channel

• Government Bidding
• Market Sales

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cattle Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Cattle Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Cattle Vaccine in country level. It provides sigmate data by Type, and by Sales Channel for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Cattle Vaccine Product Introduction
• 1.2 Global Cattle Vaccine Market Size Forecast (2020-2031)
• 1.3 Cattle Vaccine Market Trends & Drivers
  • 1.3.1 Cattle Vaccine Industry Trends
  • 1.3.2 Cattle Vaccine Market Drivers & Opportunity
  • 1.3.3 Cattle Vaccine Market Challenges
  • 1.3.4 Cattle Vaccine Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Cattle Vaccine Players Revenue Ranking (2024)
• 2.2 Global Cattle Vaccine Revenue by Company (2020-2025)
• 2.3 Key Companies Cattle Vaccine Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Cattle Vaccine Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Cattle Vaccine
• 2.6 Cattle Vaccine Market Competitive Analysis
  • 2.6.1 Cattle Vaccine Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Cattle Vaccine Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cattle Vaccine as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Live Attenuated Vaccine
  • 3.1.2 Inactivated Vaccine
  • 3.1.3 Others
• 3.2 Global Cattle Vaccine Sales Value by Type
  • 3.2.1 Global Cattle Vaccine Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Cattle Vaccine Sales Value, by Type (2020-2031)
  • 3.2.3 Global Cattle Vaccine Sales Value, by Type (%) (2020-2031)

4 Segmentation by Sales Channel

• 4.1 Introduction by Sales Channel
  • 4.1.1 Government Bidding
  • 4.1.2 Market Sales
• 4.2 Global Cattle Vaccine Sales Value by Sales Channel
  • 4.2.1 Global Cattle Vaccine Sales Value by Sales Channel (2020 VS 2024 VS 2031)
  • 4.2.2 Global Cattle Vaccine Sales Value, by Sales Channel (2020-2031)
  • 4.2.3 Global Cattle Vaccine Sales Value, by Sales Channel (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Cattle Vaccine Sales Value by Region
  • 5.1.1 Global Cattle Vaccine Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Cattle Vaccine Sales Value by Region (2020-2025)
  • 5.1.3 Global Cattle Vaccine Sales Value by Region (2026-2031)
  • 5.1.4 Global Cattle Vaccine Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Cattle Vaccine Sales Value, 2020-2031
  • 5.2.2 North America Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Cattle Vaccine Sales Value, 2020-2031
  • 5.3.2 Europe Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Cattle Vaccine Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Cattle Vaccine Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Cattle Vaccine Sales Value, 2020-2031
  • 5.5.2 South America Cattle Vaccine Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Cattle Vaccine Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Cattle Vaccine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Cattle Vaccine Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Cattle Vaccine Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Cattle Vaccine Sales Value, 2020-2031
  • 6.3.2 United States Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Cattle Vaccine Sales Value, 2020-2031
  • 6.4.2 Europe Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Cattle Vaccine Sales Value, 2020-2031
  • 6.5.2 China Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Cattle Vaccine Sales Value, 2020-2031
  • 6.6.2 Japan Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Cattle Vaccine Sales Value, 2020-2031
  • 6.7.2 South Korea Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Cattle Vaccine Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Cattle Vaccine Sales Value, 2020-2031
  • 6.9.2 India Cattle Vaccine Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Cattle Vaccine Sales Value by Sales Channel, 2024 VS 2031

7 Company Profiles

• 7.1 Merck Animal Health
  • 7.1.1 Merck Animal Health Profile
  • 7.1.2 Merck Animal Health Main Business
  • 7.1.3 Merck Animal Health Cattle Vaccine Products, Services and Solutions
  • 7.1.4 Merck Animal Health Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Merck Animal Health Recent Developments
• 7.2 Zoetis
  • 7.2.1 Zoetis Profile
  • 7.2.2 Zoetis Main Business
  • 7.2.3 Zoetis Cattle Vaccine Products, Services and Solutions
  • 7.2.4 Zoetis Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Zoetis Recent Developments
• 7.3 Boehringer Ingelheim
  • 7.3.1 Boehringer Ingelheim Profile
  • 7.3.2 Boehringer Ingelheim Main Business
  • 7.3.3 Boehringer Ingelheim Cattle Vaccine Products, Services and Solutions
  • 7.3.4 Boehringer Ingelheim Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Boehringer Ingelheim Recent Developments
• 7.4 Ceva
  • 7.4.1 Ceva Profile
  • 7.4.2 Ceva Main Business
  • 7.4.3 Ceva Cattle Vaccine Products, Services and Solutions
  • 7.4.4 Ceva Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Ceva Recent Developments
• 7.5 Zoetis
  • 7.5.1 Zoetis Profile
  • 7.5.2 Zoetis Main Business
  • 7.5.3 Zoetis Cattle Vaccine Products, Services and Solutions
  • 7.5.4 Zoetis Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.5.5 Zoetis Recent Developments
• 7.6 Elanco Animal Health
  • 7.6.1 Elanco Animal Health Profile
  • 7.6.2 Elanco Animal Health Main Business
  • 7.6.3 Elanco Animal Health Cattle Vaccine Products, Services and Solutions
  • 7.6.4 Elanco Animal Health Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Elanco Animal Health Recent Developments
• 7.7 Indian Immunologicals
  • 7.7.1 Indian Immunologicals Profile
  • 7.7.2 Indian Immunologicals Main Business
  • 7.7.3 Indian Immunologicals Cattle Vaccine Products, Services and Solutions
  • 7.7.4 Indian Immunologicals Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Indian Immunologicals Recent Developments
• 7.8 Cambridge Technologies
  • 7.8.1 Cambridge Technologies Profile
  • 7.8.2 Cambridge Technologies Main Business
  • 7.8.3 Cambridge Technologies Cattle Vaccine Products, Services and Solutions
  • 7.8.4 Cambridge Technologies Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Cambridge Technologies Recent Developments
• 7.9 Vaxxinova
  • 7.9.1 Vaxxinova Profile
  • 7.9.2 Vaxxinova Main Business
  • 7.9.3 Vaxxinova Cattle Vaccine Products, Services and Solutions
  • 7.9.4 Vaxxinova Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Vaxxinova Recent Developments
• 7.10 Jinyu Bio-Technolog
  • 7.10.1 Jinyu Bio-Technolog Profile
  • 7.10.2 Jinyu Bio-Technolog Main Business
  • 7.10.3 Jinyu Bio-Technolog Cattle Vaccine Products, Services and Solutions
  • 7.10.4 Jinyu Bio-Technolog Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Jinyu Bio-Technolog Recent Developments
• 7.11 China Animal Husbandry Industry
  • 7.11.1 China Animal Husbandry Industry Profile
  • 7.11.2 China Animal Husbandry Industry Main Business
  • 7.11.3 China Animal Husbandry Industry Cattle Vaccine Products, Services and Solutions
  • 7.11.4 China Animal Husbandry Industry Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.11.5 China Animal Husbandry Industry Recent Developments
• 7.12 Tecon Biology
  • 7.12.1 Tecon Biology Profile
  • 7.12.2 Tecon Biology Main Business
  • 7.12.3 Tecon Biology Cattle Vaccine Products, Services and Solutions
  • 7.12.4 Tecon Biology Cattle Vaccine Revenue (US$ Million) & (2020-2025)
  • 7.12.5 Tecon Biology Recent Developments

8 Industry Chain Analysis

• 8.1 Cattle Vaccine Industrial Chain
• 8.2 Cattle Vaccine Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Cattle Vaccine Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Cattle Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer